Craft

Synthorx

Stock Price

$68

2020-01-23

Market Capitalization

$2.2 B

2020-01-23

Synthorx Summary

Company Summary

Overview
Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics. The company uses new building blocks to create proteins that impart specificity not possible with native proteins. 
Type
Public
Status
Active
Founded
2014
HQ
San Diego, CA, US | view all locations
Website
http://synthorx.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Marcos Milla

    Marcos Milla, Chief Scientific Officer

    • Lauren Baker Ph, VP, Scientific Affairs and Communications

      • Eric Miller, Senior Director, Finance

        • Floyd Romesberg

          Floyd Romesberg, Founder and Distinguished Fellow

          LocationsView all

          1 location detected

          • San Diego, CA HQ

            United States

            11099 N Torrey Pines Rd #290, La Jolla

          Synthorx Financials

          Summary Financials

          Net income (Q3, 2019)
          ($12.2M)
          Cash (Q3, 2019)
          $18.5M
          EBIT (Q3, 2019)
          ($13.2M)
          Enterprise value
          $2.2B

          Footer menu